Press releases

According to Essity’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner.

Essity’s Half-year Report for 2020 will be published on July 17 at approximately 7:00 CET. In conjunction with publication, a telephone and web presentation will be held at 9:00 CET where President and CEO Magnus Groth will present and answer questions.

According to Essity’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner.

According to Essity’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner.

On account of the substantial increase in net sales and earnings for the first quarter of 2020 compared with the corresponding period a year ago, Essity is today publishing its preliminary result for the first quarter of 2020. The strong development is partially a consequence of the COVID-19 pandemic. The Group’s net sales amounted to SEK 33,712m and organic net sales increased 7.8% in the first quarter of 2020 compared with the corresponding period a year ago. Adjusted EBITA[1)] increased 67% to SEK 5,333m. 

Essity’s Annual General Meeting was held today at Stockholm Waterfront Congress Center in Stockholm, Sweden

Hygiene and health company Essity is strengthening its offering in incontinence products through the acquisition of the Dutch company Novioscan. The company develops a wearable ultrasound technology that monitors the bladder and enables continence control. The purchase price is approximately SEK 70m (EUR 6.5m) on a debt-free basis.

As a consequence of the situation concerning the coronavirus pandemic, Essity’s Nomination Committee has decided to withdraw its proposal that Essity’s Annual General Meeting on April 2, 2020 approve an increase in Board fees (item 11 on the agenda). 

At the Annual General Meeting on April 2, 2020, the Board of Directors will propose that the Meeting postpones a decision regarding the dividend for 2019 until an Extraordinary General Meeting no later than November 2020. The Board of Directors’ previous assessment of a dividend of SEK 6.25 per share remains. The final assessment on the size of the dividend will, however, be taken at a later date when the effects of the current COVID-19 pandemic are better understood.